The KCNK3 Gene and Pulmonary Arterial Hypertension

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

In this video, shared by Rare Disease Report in 2013, the role of KCNK3 gene mutations in patients with pulmonary arterial hypertension is discussed. Listen to Dr. Wendy Chung, from Columbia University, talk about how a team of researchers identified a new gene mutation that can be pointed as responsible for the development of PAH in some patients.

Read the latest updates on pulmonary hypertension:

Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.